Eftilagimod alfa Antibody

Eftilagimod alfa is a soluble LAG-3 fusion protein that activates antigen-presenting cells via MHC class II binding, leading to subsequent CD8+ T-cell stimulation. Its research applications include investigations in metastatic melanoma and breast cancer, with studies encompassing both in vitro immune activation assays and in vivo clinical trials.